Macrophage activation syndrome: A potentially fatal complication of kawasaki disease

Archives of Rheumatology

Volumn 30, Issue 2, 2015, Pages 178-180

  Bose, Kallol ^a   Saha, Sudip ^a   Saha, Prabir ^a   Mondal, Piyasi ^a  

^a Department of Pediatrics Chittaranjan Seva Sadan Hospital   (India)

Author keywords

Immunoglobulin; Kawasaki disease; Macrophage activation syndrome

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; DEXAMETHASONE; IMMUNOGLOBULIN;

ARTICLE; BLOOD CLOTTING TEST; BONE MARROW BIOPSY; CASE REPORT; CHILD; CONJUNCTIVITIS; ECHOCARDIOGRAPHY; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HEPATOSPLENOMEGALY; HUMAN; IRRITABILITY; MACROPHAGE ACTIVATION SYNDROME; MUCOCUTANEOUS LYMPH NODE SYNDROME; PANCYTOPENIA; PHAGOCYTOSIS; PRESCHOOL CHILD;

EID: 84940659881     PISSN: 21485046     EISSN: None     Source Type: Journal    
DOI: 10.5606/ArchRheumatol.2015.5186     Document Type: Article

References (11)

1. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421-6.
2. Ziaee V, Moardinejad MH. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Pediatr Rheumatol (Serial Online) 2008;6(1): (62 screens). Available from: http://www.ped-rheum. com/content/6/S1/P62.
3. Mashuku S, Hibi S, Todo S. Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr 1997;130:352-7.
4. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974;54:271-6.
5. Muise A, Tallett SE, Silverman ED. Are Children With Kawasaki Disease and Prolonged Fever at Risk for Macrophage Activation Syndrome? (serial online) Pediatrics 2003;112(495497 screens).Available from: http://pediatrics.aappublications.org/content/112/6/ e495.full.html
6. Wright, DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulse doses of corticosteroids. J Pediatr 1996;128:146-9.
7. Kuzmanova SI. The macrophage activation syndrome: a new entity, a potentially fatal complication of rheumatic disorders. Folia Med (Plovdiv) 2005;47:21-5.
8. Ramanan AV, Schneider R. Macrophage activation syndrome-what's in a name! J Rheumatol 2003;30:2513-6.
9. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421-6.
10. Latino GA, Manlhiot C, Yeung RS, Chahal N, McCrindle BW. Macrophage activation syndrome in the acute phase of Kawasaki disease. J Pediatr Hematol Oncol 2010;32:527-31.
11. McClain KL.Treatment and prognosis of hemophagocytic lymphohistiocytosis. Available from: http://www. w3.org/TR/html4/strict. [Accessed 10th July 2014]